We believe Strong Global Entertainment is positioned to be a leader in the entertainment industry, as Ballantyne has provided mission critical products and services to cinema exhibitors and entertainment venues for over 80 years. (Incorporated in British Columbia) (**Note: After the IPO, our parent, FG Holdings, formerly known as Ballantyne Strong, will  control a majority […]

We intend to focus on a prospective target business in the “space economy”, taking advantage of the transformational commercialization of space, driven by recent and ongoing significant cost decreases of accessing and operating in space. Such prospective target businesses will likely have enterprise values of $1 billion or more, be positioned to be market leaders and […]

Sectors of interests include financial technology, consumer technology and medical technology as well as advanced mobility technology. We shall not undertake our initial business combination with any entity based in or with the majority of its operations in China, including Hong Kong and Macau. (Incorporated in Delaware) We will seek to capitalize on the collective deal-making […]

(Note: Hony Capital Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 28, 2022. This Hong Kong-based special-purpose acquisition company (SPAC), or blank-check company, filed its S-1 on March 23, 2021, with initial plans to offer 30 million units at $10 each to raise $300 million. Hony Capital Acquisition Corp. downsized its […]

(Note: This IPO is a unit offering of American Depositary Shares (ADS) and warrants on the NASDAQ. Each unit consists of one ADS and one warrant to buy one ADS. The ordinary shares trade on the Australian Stock Exchange (ASX). Each ADS represents 275 ordinary shares; that ratio marks a change on Aug. 16, 2022, […]

We are a biotechnology company focused on the development, manufacture, and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. Using our patents, proprietary technology and know-how, we develop and sell products that, under certain conditions, are a possible alternative to blood transfusions […]

(Note: Queen’s Gambit Growth Capital II withdrew its SPAC IPO on April 26, 2022. The S-1 was filed on Feb. 23, 2021.) Queens Gambit Growth Capital II is the second blank-check company created by venture capitalist Victoria Grace. This SPAC or blank-check company, like the first Queen’s Gambit Growth Capital, has an all-female management team. […]

High-quality tech businesses with growth and large addressable markets are the focus of this special purpose acquisition company (SPAC), also known as a blank check company. (Incorporated in Delaware)  (Note: Stillwater Growth Corp. 1 slashed the size of its SPAC IPO by one-third to 20 million units, down from 30 million units initially, at $10 each […]

(Note: Intrinsic Medicine, Inc. withdrew its IPO plans in an SEC filing dated July 25, 2022. The preclinical therapeutics company had filed to go public on April 8, 2022.) We are a preclinical-stage therapeutics company leveraging synthetic biology-manufactured human identical milk oligosaccharide, or HiMO, molecules as new medicines to treat large patient populations underserved by […]

(Note: This tiny biotech IPO is a unit offering. IPOScoop has NO CALL on unit offerings that are not SPACs.) (Note: From the S-1/A (prospectus) dated July 28, 2022: “In connection with this Offering, our Board of Directors and stockholders approved a 1-for-7 reverse stock split of our Common Stock, which became effective with the State […]